A generic version of the drug is advertised as Pexeva
. In Europe, paroxetine is sold under the name of Seroxat (Schatzberg & DeBattista, 2002).
has launched Pexeva (paroxetine mesylate), promising it will bring savings to patients under selective serotonin reuptake inhibitor (SSRI) therapy.
Pexeva is also the first product that Synthon has rolled out in the U.S.
"Pexeva provides physicians, pharmacists and--most important--patients with a branded, safe, effective and more affordable alternative to other SSRI therapies.
Paroxetine mesylate, first approved in 2003 and marketed as Pexeva
, is approved for major depressive disorder, obsessive compulsive disorder, panic disorder, and generalized anxiety.
* Antidepressants used to treat major depressive disorder: the serotonin-norepinephrine reuptake inhibitor venlafaxine (Effexor) and the selective serotonin reuptake inhibitors fluoxetine (Prozac) and paroxetine (Paxil, Pexeva